ArticleAmerican journal of epidemiology2026
Oral Nicotine Product Use and E-Cigarette Use Persistence in Adolescents and Young Adults: An Analysis Using Augmented Inverse Probability Weighting.
Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The impact of oral nicotine product (ONP) use on e-cigarette use persistence among adolescents and young adults (AYA) remains unclear. We applied augmented inverse probability weighting (AIPW) with machine learning (ML) to reduce bias from model misspecification and improve precision of treatment effect estimates. We combined data from two Southern California cohorts of adolescents (n=269; M[SD]=16.3[0.6] years) and young adults (n=449; age M[SD]=23.4[0.4] years) who reported past 6-month e-cigarette use at baseline in 2022 and were re-assessed an average of 8 months later in 2023. We examined the effects of baseline ONP use on e-cigarette use persistence using AIPW with ML, with analyses stratified by age group. Among 718 AYAs (53.1% female; 58.4% Hispanic), 14.2% reported ONP use at baseline and 64.3% reported persistent e-cigarette use at follow-up. Adolescents who used ONPs had a lower risk of e-cigarette persistence compared with non-users (risk difference=-0.18, 95% CI=-0.31, -0.04; risk ratio=0.70, 95% CI=0.52, 0.95), whereas no association was observed among young adults. Findings suggest ONPs may serve as a partial substitute for e-cigarettes among adolescents, but not young adults. Regulatory policies should balance potential harm-reduction benefits with age-specific risks and address dual e-cigarette and ONP among young adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.